References
- Hughes AL. Evolution of the integrin alpha and beta protein families. J Mol Evol 2001;52:63-72. https://doi.org/10.1007/s002390010134
- Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-26. https://doi.org/10.1038/nrm1490
- Guo L, Zhang F, Cai Y, Liu T. Expression profiling of integrins in lung cancer cells. Pathol Res Pract 2009;205:847-53. https://doi.org/10.1016/j.prp.2009.07.005
- Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986;319:226-30. https://doi.org/10.1038/319226a0
- Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004;59(2 Suppl):21-6. https://doi.org/10.1016/j.ijrobp.2003.10.027
- Ishitoya J, Toriyama M, Oguchi N, et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 1989;59:559-62. https://doi.org/10.1038/bjc.1989.113
- Neve RM, Lane HA, Hynes NE. The role of overexpressed HER2 in transformation. Ann Oncol 2001;12 Suppl 1:S9-13. https://doi.org/10.1093/annonc/12.suppl_1.S9
- Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12. https://doi.org/10.1016/0092-8674(90)90801-K
- Young NR, Liu J, Pierce C, et al. Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition. Mol Oncol 2012. pii: S1574-7891(12)00121-4.
- Markovic A, Chung CH. Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 2012;12:1149-59. https://doi.org/10.1586/era.12.91
- Kim KW, Kim MJ. Expression of the epidermal growth factor receptor and cell cycle analysis in the head and neck squamous cell carcinomas. J Korean Assoc Oral Maxillofac Surg 2000;26:154-63.
- Moon BC, Han SJ, Jeong D, Kim KW. Epidermal growth factor receptor overexpression and K-ras mutation detection in the oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg 2011;37:396-402. https://doi.org/10.5125/jkaoms.2011.37.5.396
- Fridman G, Fridman G, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Process Polym 2008;5:503-33. https://doi.org/10.1002/ppap.200700154
- Fridman G, Shereshevsky A, Jost MM, et al. Floating elctrode dielectric barrier discharge plasma in air promoting apoptotic behavior in melanoma skin cancer cell lines. Plasma Chem Plasma Process 2007;27:163-76. https://doi.org/10.1007/s11090-007-9048-4
- Kim CH, Kwon S, Bahn JH, et al. Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells. Appl Phys Lett 2010;96:243701. https://doi.org/10.1063/1.3449575
- Kim D, Gweon B, Kim DB, Choe W, Shin JH. A feasibility study for the cancer therapy using cold plasma. ICBME Proc 2008;23:355-7.
- Kim GC, Lee HJ, Shon H. The effects of a micro plasma on melanoma (G361) cancer cells. J Korean Phys Soc 2009;54:628-32. https://doi.org/10.3938/jkps.54.628
- Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005;1:325-7. https://doi.org/10.1002/smll.200400093
- Thomas M, Klibanov AM. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 2003;100:9138-43. https://doi.org/10.1073/pnas.1233634100
- Levy JM, Thorburn A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 2011;131:130-41. https://doi.org/10.1016/j.pharmthera.2011.03.009
- Chen CS, Alonso JL, Ostuni E, Whitesides GM, Ingber DE. Cell shape provides global control of focal adhesion assembly. Biochem Biophys Res Commun 2003;307:355-61. https://doi.org/10.1016/S0006-291X(03)01165-3
- Riveline D, Zamir E, Balaban NQ, et al. Focal contacts as mechanosensors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol 2001;153:1175-86. https://doi.org/10.1083/jcb.153.6.1175
- Zamir E, Geiger B. Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci 2001;114:3583-90.
- Ennis BW, Lippman ME, Dickson RB. The EGF receptor system as a target for antitumor therapy. Cancer Invest 1991;9:553-62. https://doi.org/10.3109/07357909109018953
- Mendelsohn J, Baselga J. Epidermal growth factor receptor targeting in cancer. Semin Oncol 2006;33:369-85. https://doi.org/10.1053/j.seminoncol.2006.04.003
- Ghavami S, Hashemi M, Ande SR, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet 2009;46:497-510. https://doi.org/10.1136/jmg.2009.066944
- Dejean LM, Martinez-Caballero S, Manon S, Kinnally KW. Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta 2006;1762:191-201. https://doi.org/10.1016/j.bbadis.2005.07.002
- Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6. https://doi.org/10.1038/17135
- Dejean LM, Martinez-Caballero S, Kinnally KW. Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis? Cell Death Differ 2006;13:1387-95. https://doi.org/10.1038/sj.cdd.4401949
- Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171. https://doi.org/10.1016/S0092-8674(00)81334-3
- Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M, Lock RB. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ 2000;7:102-11. https://doi.org/10.1038/sj.cdd.4400597
- Yu SW, Andrabi SA, Wang H, et al. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci U S A 2006;103:18314-9. https://doi.org/10.1073/pnas.0606528103
- Widłak P. The DFF40/CAD endonuclease and its role in apoptosis. Acta Biochim Pol 2000;47:1037-44.
- Karam JA. Apoptosis in carcinogenesis and chemotherapy. Netherlands: Springer; 2009.
- Morgan DO. Principles of CDK regulation. Nature 1995;374:131-4. https://doi.org/10.1038/374131a0
- Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79:551-5. https://doi.org/10.1016/0092-8674(94)90540-1
- Pines J. Cyclins: wheels within wheels. Cell Growth Differ 1991;2:305-10.
- Si X, Liu Z. Expression and significance of cell cycle-related proteins Cyclin DI, CDK4, p27, E2F-I and Ets-1 in chondrosarcoma of the jaws. Oral Oncol 2001;37:431-6. https://doi.org/10.1016/S1368-8375(00)00091-9
- Kim GC, Kim GJ, Park SR, et al. Air plasma coupled with antibody-conjugated nanoparticles: a new weapon against cancer. J Phys D Appl Phys 2009;42:032005. https://doi.org/10.1088/0022-3727/42/3/032005
- Choi BB, Choi YS, Lee HJ, Lee JK, Kim UK, Kim GC. Nonthermal plasma-mediated cacer cell death: targeted cancer treatment. J Therm Sci Technol 2012;7:399-404. https://doi.org/10.1299/jtst.7.399